- Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
- Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
- Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
- Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
- Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
More ▼
Key statistics
On Wednesday, Astria Therapeutics Inc (ATXS:NMQ) closed at 9.00, 111.27% above the 52 week low of 4.26 set on Nov 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.00 |
---|---|
High | 9.17 |
Low | 8.94 |
Bid | 8.64 |
Offer | 10.84 |
Previous close | 8.97 |
Average volume | 481.85k |
---|---|
Shares outstanding | 54.91m |
Free float | 48.16m |
P/E (TTM) | -- |
Market cap | 494.22m USD |
EPS (TTM) | -2.32 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼